Joseph Holson has more than 35 years of experience as a scientist, business executive, and educator in the disciplines of toxicology and product development. His internationally recognized expertise in developmental and reproductive toxicology, pharmacokinetics, and risk assessment, including extensive experience with study design, data interpretation, and interspecies extrapolation of health effects data, strengthened his executive leadership of WIL Research Laboratories through two decades of continuous growth. Dr. Holson has functioned as a key advisor to numerous product development programs (INDs, NDAs, TCSA consent orders, FIFRA registrations and international product registrations) and has served as principle investigator in more than 600 safety assessment studies. These projects involved diverse test agents using a variety of experimental animal models and human studies. He has served in numerous U.S. EPA/FDA advisory committees and as an expert toxicology witness for these agencies and in 27 civil lawsuits. He was elected to two National Academy of Sciences toxicology committees. He has been a long-standing member of numerous national and international professional societies, serving in a variety of roles. Throughout his career, including his tenure as President of WIL Research, Dr. Holson has lectured and published extensively in the fields of toxicology and human health risk assessment. At each phase of his career, he has complemented his research and executive responsibilities with regular adjunct teaching activities in toxicology programs of nearby universities.